Guarantor Financial Information Condensed Consolidated Statements of Cash Flows (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Jan. 01, 2011		Jan. 02, 2010
Cash flows from operating activities:
Net income	$ 169,418		$ 44,243		$ 41,790
Earnings in investments in subsidiaries	0		0		0
Other operating cash flows	71,446		37,267		37,396
Net cash provided by operating activities	240,864		81,510		79,186
Cash flows from investing activities:
Capital expenditures	(60,153)	[1]	(24,720)	[1]	(23,638)	[1]
Acquisitions, net of cash acquired	(1,754)		(758,182)		(33,987)
Investment in unconsolidated subsidiary	(23,305)		0		0
Gross proceeds from sale of property, plant and equipment and other assets	1,529		624		1,913
Payments related to routes and other intangibles	0		(1,367)		0
Net cash used by investing activities	(83,683)		(783,645)		(55,712)
Cash flows from financing activities:
Proceeds from long-term debt	0		550,000		48
Payments on long-term debt	(270,009)		(32,509)		(5,000)
Borrowings from revolving credit facility	131,000		160,000		0
Payments on revolving credit facility	(291,000)		0		0
Contract payments	0		0		(72)
Deferred loan costs	(399)		(24,020)		(946)
Issuance of common stock	293,117		35		11
Minimum withholding taxes paid on stock awards	(1,281)		(585)		(108)
Excess tax benefits from stock-based compensation	1,125		234		(39)
Net cash provided/(used) in financing activities	(137,447)		653,155		(6,106)
Net increase/(decrease) in cash and cash equivalents	19,734		(48,980)		17,368
Cash and cash equivalents at beginning of year	19,202		68,182		50,814
Cash and cash equivalents at end of year	38,936		19,202		68,182
Issuer [Member]
Cash flows from operating activities:
Net income	169,418		44,243		41,790
Earnings in investments in subsidiaries	(145,950)		(22,258)		(20,235)
Other operating cash flows	160,697		46,624		53,849
Net cash provided by operating activities	184,165		68,609		75,404
Cash flows from investing activities:
Capital expenditures	(23,835)		(17,648)		(18,078)
Acquisitions, net of cash acquired	(1,754)		(758,182)		(33,987)
Investment in unconsolidated subsidiary	0
Gross proceeds from sale of property, plant and equipment and other assets	961		406		177
Payments related to routes and other intangibles			(1,367)
Net cash used by investing activities	(24,628)		(776,791)		(51,888)
Cash flows from financing activities:
Proceeds from long-term debt			550,000		0
Payments on long-term debt	(270,000)		(32,500)		(5,000)
Borrowings from revolving credit facility	131,000		160,000
Payments on revolving credit facility	(291,000)
Contract payments					(72)
Deferred loan costs	(399)		(24,020)		(946)
Issuance of common stock	293,117		35		11
Minimum withholding taxes paid on stock awards	(1,281)		(585)		(108)
Excess tax benefits from stock-based compensation	1,125		234		(39)
Net cash provided/(used) in financing activities	(137,438)		653,164		(6,154)
Net increase/(decrease) in cash and cash equivalents	22,099		(55,018)		17,362
Cash and cash equivalents at beginning of year	13,108		68,126		50,764
Cash and cash equivalents at end of year	35,207		13,108		68,126
Guarantors [Member]
Cash flows from operating activities:
Net income	146,584		22,598		20,569
Earnings in investments in subsidiaries	0		0		0
Other operating cash flows	(114,532)		(10,311)		(16,787)
Net cash provided by operating activities	32,052		12,287		3,782
Cash flows from investing activities:
Capital expenditures	(36,318)		(7,072)		(5,560)
Acquisitions, net of cash acquired	0		0		0
Investment in unconsolidated subsidiary	0
Gross proceeds from sale of property, plant and equipment and other assets	568		218		1,736
Payments related to routes and other intangibles			0
Net cash used by investing activities	(35,750)		(6,854)		(3,824)
Cash flows from financing activities:
Proceeds from long-term debt			0		48
Payments on long-term debt	(9)		(9)		0
Borrowings from revolving credit facility	0		0
Payments on revolving credit facility	0
Contract payments					0
Deferred loan costs	0		0		0
Issuance of common stock	0		0		0
Minimum withholding taxes paid on stock awards	0		0		0
Excess tax benefits from stock-based compensation	0		0		0
Net cash provided/(used) in financing activities	(9)		(9)		48
Net increase/(decrease) in cash and cash equivalents	(3,707)		5,424		6
Cash and cash equivalents at beginning of year	5,480		56		50
Cash and cash equivalents at end of year	1,773		5,480		56
Non-guarantors [Member]
Cash flows from operating activities:
Net income	(634)		(340)		(334)
Earnings in investments in subsidiaries	0		0		0
Other operating cash flows	25,281		954		334
Net cash provided by operating activities	24,647		614		0
Cash flows from investing activities:
Capital expenditures	0		0		0
Acquisitions, net of cash acquired	0		0		0
Investment in unconsolidated subsidiary	(23,305)
Gross proceeds from sale of property, plant and equipment and other assets	0		0		0
Payments related to routes and other intangibles			0
Net cash used by investing activities	(23,305)		0		0
Cash flows from financing activities:
Proceeds from long-term debt			0		0
Payments on long-term debt	0		0		0
Borrowings from revolving credit facility	0		0
Payments on revolving credit facility	0
Contract payments					0
Deferred loan costs	0		0		0
Issuance of common stock	0		0		0
Minimum withholding taxes paid on stock awards	0		0		0
Excess tax benefits from stock-based compensation	0		0		0
Net cash provided/(used) in financing activities	0		0		0
Net increase/(decrease) in cash and cash equivalents	1,342		614		0
Cash and cash equivalents at beginning of year	614		0		0
Cash and cash equivalents at end of year	1,956		614		0
Eliminations [Member]
Cash flows from operating activities:
Net income	(145,950)		(22,258)		(20,235)
Earnings in investments in subsidiaries	145,950		22,258		20,235
Other operating cash flows	0		0		0
Net cash provided by operating activities	0		0		0
Cash flows from investing activities:
Capital expenditures	0		0		0
Acquisitions, net of cash acquired	0		0		0
Investment in unconsolidated subsidiary	0
Gross proceeds from sale of property, plant and equipment and other assets	0		0		0
Payments related to routes and other intangibles			0
Net cash used by investing activities	0		0		0
Cash flows from financing activities:
Proceeds from long-term debt			0		0
Payments on long-term debt	0		0		0
Borrowings from revolving credit facility	0		0
Payments on revolving credit facility	0
Contract payments					0
Deferred loan costs	0		0		0
Issuance of common stock	0		0		0
Minimum withholding taxes paid on stock awards	0		0		0
Excess tax benefits from stock-based compensation	0		0		0
Net cash provided/(used) in financing activities	0		0		0
Net increase/(decrease) in cash and cash equivalents	0		0		0
Cash and cash equivalents at beginning of year	0		0		0
Cash and cash equivalents at end of year	$ 0		$ 0		$ 0

[1] Excludes the capital assets acquired as part of the acquisition of assets related to the Griffin Transaction and Nebraska Transaction in fiscal 2010 of approximately$243.7 million, the Sanimax Transaction and Boca Transaction in fiscal 2009 of approximately $8.0 million